Inhibrx Announces Participation in Upcoming Investor and Scientific Conferences

Rhea-AI Summary

Inhibrx, a clinical-stage biotechnology company (Nasdaq: INBX), announced its participation in several upcoming investor and scientific conferences. Presentations will occur at the:

• The 29th Annual Credit Suisse Virtual Healthcare Conference on November 12 at 3:30 p.m. ET,
• Jefferies Virtual London Healthcare Conference on November 17 at 2:10 p.m. ET,
• CTOS 2020 Virtual Annual Meeting on November 20 at 9:00 a.m. ET,
• Evercore's Annual Conference on December 3 at 3:30 p.m. ET.

Each event will be available via live webcast on their investor website.

SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today that the Company will be presenting at the following upcoming virtual investor and scientific conferences:

• The 29^th Annual Credit Suisse Virtual Healthcare Conference; Thursday, November 12th at 3:30 p.m. Eastern Time;
     
• Jefferies Virtual London Healthcare Conference; Tuesday, November 17th at 2:10 p.m. Eastern Time;

• CTOS 2020 Virtual Annual Meeting; Friday, November 20th at 9:00 a.m. Eastern Time; and
   
• Evercore's Annual Conference; Thursday, December 3rd at 3:30 p.m. Eastern Time

Each investor conference presentation will be webcast live and may be accessed through a link on the investors section of Inhibrx's website at https://inhibrx.investorroom.com/events-and-presentations. The webcasts will be available for 60 days following the events.

About Inhibrx, Inc.

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi. For more information, please visit www.inhibrx.com.

Investor and Media Contact:

Amy Conrad
Juniper Point
amy@juniper-point.com
858-366-3243

View original content:http://www.prnewswire.com/news-releases/inhibrx-announces-participation-in-upcoming-investor-and-scientific-conferences-301167423.html

SOURCE Inhibrx, Inc.

FAQ

What is the schedule for Inhibrx's upcoming conferences in November 2020?

Inhibrx will present at the Credit Suisse Virtual Healthcare Conference on November 12 at 3:30 p.m. ET, and the Jefferies Virtual London Healthcare Conference on November 17 at 2:10 p.m. ET.

When will the CTOS 2020 Virtual Annual Meeting take place?

The CTOS 2020 Virtual Annual Meeting is scheduled for November 20, 2020, at 9:00 a.m. ET.

What time is Inhibrx presenting at the Evercore's Annual Conference?

Inhibrx will present at Evercore's Annual Conference on December 3, 2020, at 3:30 p.m. ET.

How can I access Inhibrx's conference presentations?

Inhibrx's conference presentations will be webcast live and can be accessed through their investor section on the website.

Where can I find more information about Inhibrx?

More information about Inhibrx can be found on their official website at www.inhibrx.com.